158 related articles for article (PubMed ID: 37373883)
1. Using Fetal Fibronectin Test to Reduce Hospital Admissions with Diagnosis of Preterm Labor: An Economic Evaluation Study.
Amro B; Alhalabi I; George A; Haroun H; Khamis AH; Sawalhi NA
J Pers Med; 2023 May; 13(6):. PubMed ID: 37373883
[No Abstract] [Full Text] [Related]
2. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
[TBL] [Abstract][Full Text] [Related]
3. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
Peláez LM; Fox NS; Chasen ST
J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
[TBL] [Abstract][Full Text] [Related]
4. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
[TBL] [Abstract][Full Text] [Related]
5. [Economical impact of preterm delivery management based on fetal fibronectin results].
García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
[TBL] [Abstract][Full Text] [Related]
6. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
[TBL] [Abstract][Full Text] [Related]
7. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
Berghella V; Saccone G
Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.
Hermans FJR; Bruijn MMC; Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HCJ; Bloemenkamp KWM; Bax CJ; Cornette JMJ; Nij Bijvanck BWA; Franssen MTM; Vandenbussche FPHA; Kok M; Grobman WA; Van Der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ; Schuit E; Van Baaren GJ
Acta Obstet Gynecol Scand; 2015 Jul; 94(7):715-721. PubMed ID: 25845495
[TBL] [Abstract][Full Text] [Related]
9. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
Ng VWY; Seto MTY; Lewis H; Cheung KW
BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of fetal fibronectin for threatened preterm labour in reducing inappropriate interventions.
Mahomed K; Anwar S; Geer JE; Ballard E; Okano S
Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):523-527. PubMed ID: 30393916
[TBL] [Abstract][Full Text] [Related]
11. Does availability of fetal firbonectin testing in the management of threatened preterm labour affect the utilization of hospital resources?
Abenhaim HA; Morin L; Benjamin A
J Obstet Gynaecol Can; 2005 Jul; 27(7):689-94. PubMed ID: 16100624
[TBL] [Abstract][Full Text] [Related]
12. Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor.
Blackwell SC; Sullivan EM; Petrilla AA; Shen X; Troeger KA; Byrne JD
Clinicoecon Outcomes Res; 2017; 9():585-594. PubMed ID: 29042802
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).
Hermans FJ; Schuit E; Opmeer BC; Oudijk MA; Bekker M; Woiski M; Bax CJ; Sueters M; Scheepers HC; Franssen MT; Pajkrt E; Mol BW; Kok M
BMC Pregnancy Childbirth; 2016 Jul; 16(1):154. PubMed ID: 27405353
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics and preterm labor.
Stetzer BP; Mercer BM
Clin Obstet Gynecol; 2000 Dec; 43(4):809-17. PubMed ID: 11100298
[TBL] [Abstract][Full Text] [Related]
15. Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 year.
Parisaei M; Currie J; O'Gorman N; Morris S; David AL
J Obstet Gynaecol; 2016 Oct; 36(7):888-892. PubMed ID: 27147420
[TBL] [Abstract][Full Text] [Related]
16. Fetal fibronectin test for threatened preterm delivery 48h after admission: Cost-effectiveness study.
Mourgues C; Rossi A; Favre N; Delabaere A; Roszyk L; Sapin V; Debost-Legrand A; Gallot D
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():75-78. PubMed ID: 30660942
[TBL] [Abstract][Full Text] [Related]
17. Use of the fetal fibronectin assay to avert unnecessary hospitalization and bedrest in patients with preterm labor symptoms: a cost analysis.
Grover CM
Prim Care Update Ob Gyns; 1998 Jul; 5(4):178-179. PubMed ID: 10838332
[TBL] [Abstract][Full Text] [Related]
18. The fetal fibronectin test is superior to cervical length measurement in predicting preterm birth in twin pregnancies: a retrospective observational study.
Holzer I; Koch-Trappel M; Leitich H; Meyer EL; Farr A; Helmer H
Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():22-25. PubMed ID: 32058186
[TBL] [Abstract][Full Text] [Related]
19. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
Stock SJ; Horne M; Bruijn M; White H; Heggie R; Wotherspoon L; Boyd K; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David A; Khalil A; Shennan A; Baaren GV; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol B; Riley RD; Norman J; Norrie J
Health Technol Assess; 2021 Sep; 25(52):1-168. PubMed ID: 34498576
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of bedside fetal fibronectin testing varies according to treatment algorithm.
Sullivan A; Hueppchen NA; Satin AJ
J Matern Fetal Med; 2001 Dec; 10(6):380-4. PubMed ID: 11798447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
